Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: Montana Wildhack who wrote (4058)	4/10/2000 10:09:00 AM
From: Ron Nairn	Read Replies (1) \| Respond to of 14101

Here's the entire release from Newswire with the Balance Sheet and P & L. newswire.ca Rondo

To: Montana Wildhack who wrote (4058)	4/10/2000 6:09:00 PM
From: DaveAu	Read Replies (1) \| Respond to of 14101

Wolf, Over 200 patients of 240 enrolled in WF10 trial. It's not clear from that release if that is as of quarter end or as of today. It shouldn't take much more than 3 months to complete (201 patients in ~17 months is almost 12 a month). Anyone know when the Salvage Therapy conference is ? Also, when is that conference where the fungal results are begin reported? I think its May but I've forgotten. Dave

To: Montana Wildhack who wrote (4058)	4/11/2000 5:39:00 PM
From: Mark Bartlett	Read Replies (2) \| Respond to of 14101

Wolf et al, Well -- I am going back to buying as of tomorrow. I think we are going to have some news in the next 6 weeks and that it will be enough to reestablish the previous highs that DMX saw a few weeks ago. Also learned that there is an ongoing trial (in Germany only)with WF10 for the treatment of prostate cancer. The Scavaging Therapy conference is happening tomorrow and for the next few days. The WF10 researchers will be presenting safety data from the ongoing WF10 trial -- data that I understand is quite positive. Best to all, MB